Showing results (1511-1520 of 1,541) with videos related to
Sort By:
Pageof 155
Science Advances|July 7, 2023
Identifying high-grade serous ovarian carcinoma-specific extracellular vesicles by polyketone-coated nanowiresAkira Yokoi, Mayu Ukai, Takao Yasui, et al.Plos One|January 2, 2024
Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational studyMachiko Kai, Hayato Hikita, Maesaka Kazuki, et al.Journal of Gastroenterology|October 26, 2025
Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinomaKazuki Maesaka, Hayato Hikita, Yuki Tahata, et al.Biochemical and Biophysical Research Communications|September 10, 2009
Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4Kiyoshi Kikuchi, Salunya Tancharoen, Fumiyo Matsuda, et al.Biochemical and Biophysical Research Communications|April 22, 2009
Minocycline attenuates both OGD-induced HMGB1 release and HMGB1-induced cell death in ischemic neuronal injury in PC12 cellsKiyoshi Kikuchi, Ko-ichi Kawahara, Kamal Krishna Biswas, et al.Journal of Gastroenterology|April 21, 2026
On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 yearsTetsuya Hosaka, Hayato Hikita, Yuki Tahata, et al.Bone Marrow Transplantation|March 24, 2020
Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndromeSeitaro Terakura, Tetsuya Nishida, Masashi Sawa, et al.Experimental and Therapeutic Medicine|November 9, 2012
HMGB1: A new marker for estimation of the postmortem intervalKiyoshi Kikuchi, Ko-Ichi Kawahara, Kamal Krishna Biswas, et al.International Journal of Hematology|December 13, 2023
Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)Kensuke Usuki, Shigeki Ohtake, Sumihisa Honda, et al.International Journal of Hematology|November 28, 2023
Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)Kensuke Usuki, Shigeki Ohtake, Sumihisa Honda, et al.Pageof 155